Greenrise Global Brands Inc. (bisher AMP Alternative Medical Products) (Seite 155)

[techinvestor69]

AMP only enters into supply agreements with Canadian licenced producers who can supply a minimum of 1,000 kg annually of AMP branded medical cannabis, shipped on a monthly basis. AMP is in negotiations with several Canadian licenced producers to begin shipments in the fall of this year.

[traummadl]

Antwort auf Beitrag Nr.: 63.936.285 von techinvestor69 am 08.06.20 08:03:33

Warum nicht gleich so😉

[techinvestor69]

News!!!

AMP German Cannabis Group to develop medical cannabis brands for the German market

Canada NewsWire

ERFURT, Germany and BERLIN, June 8, 2020

AMP is fully licenced to import medical cannabis from Europe and other countries
Building brands for the German medical cannabis market supplied by foreign licenced producers
Large volume Canadian imports projected to begin in the fall of 2020 under AMP brand

ERFURT, Germany and BERLIN, June 8, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) announces it is developing medical brands for a range of cannabis flower strains, extracts and other novel dosage forms specifically for the German market supplied by foreign licenced medical cannabis producers. Licensed producers that have been EU-GMP certified will cultivate medical cannabis to AMP's brand specifications and quality standards.

CSE:XCX (CNW Group/AMP German Cannabis Group Inc.)

First large imports of AMP's medical cannabis brand are expected to be coming from Canada during the fall of 2020 from licenced producers that were EU-GMP certified prior to COVID-19 pandemic. AMP only enters into supply agreements with Canadian licenced producers who can supply a minimum of 1,000 kg annually of AMP branded medical cannabis, shipped on a monthly basis. AMP is in negotiations with several Canadian licenced producers to begin shipments in the fall of this year.

AMP is advancing its other signed Canadian producers to be EU-GMP audited during the fall of 2020 by the Company's German pharmaceutical consultant and inspected for certification during early 2021 by TLV (the Thuringian State Office for Consumer Protection) provided international travel restrictions are normalized. Because of the COVID-19 pandemic, Germany is not conducting inspections of foreign medical cannabis producers until the end of 2020.

To meet future demand as the German market grows, AMP is developing long-term supply sources in Europe for large scale supply of AMP medical cannabis branded products. The Company believes as the German market develops, Europe will become an important and significant medical cannabis supply source. AMP's strategy is to develop exclusive relationships with large medical cannabis licenced producers in certain EU countries for AMP medical cannabis branded products for the German market.

AMP's non-exclusive distribution agreement (see press release dated 16thOctober 2019) with a leading distributor of pharmaceuticals products to more than 13,000 pharmacies throughout Germany encompasses purchasing AMP medical cannabis branded products. In addition, under our lead pharmaceutical distributor's program, AMP will be investing in physician and pharmacist's education seminars across Germany about medical cannabis. The Company is also in negotiations with additional pharmaceutical distributors to purchase AMP medical cannabis branded products as AMP's imports increases this fall.

Dr. Stefan Feuerstein, Director of AMP, commented: "We had hoped to fulfill our distribution agreement with our lead pharmaceutical distributor in regards to imports from the Netherlands this month but we are optimistic that the Netherlands will resolve its export quota to Germany and increase exports in the near future. As already mentioned, we are in advanced negotiations with several foreign cannabis producers who already have an EU-GMP certification and are expecting to sign at least one definitive supply agreement within the next four weeks. Beginning this fall, AMP will be selling AMP branded medical cannabis products imported from Canada into Germany."

[traummadl]

Jetzt schon Abverkauf,ich hoffe es geht nicht unter 0,20

[Imvestor]

Antwort auf Beitrag Nr.: 63.933.354 von Realdeal99 am 07.06.20 17:21:42

Was ich etwas schade finde ist, dass man nicht direkt einen richtigen Plan B mit in die Pressemitteilung eingebunden hat.
Ein klarer "Fahrplan" würde erstens jeglichen Spekulationsraum nehmen und zweitens die Anleger beruhigen und evtl. so den Kurs wahren. Kann ja sein, dass morgen aufgrund der News viele werfen.
Aber den Punkt Kommunikation und AMP hatten wir ja bereits schon des öfteren als Thema.

[luckytrades]

Das mit den fortgeschrittenen Verhandlungen ist doch nur Blabla damit morgen der Kurs nicht abschmiert. Wenn alle ihre Zertifizierung haben, woran liegt es denn? In can sitzen sie LP doch alle auf Bergen von Blüten.

Fakt: ohne Ware kein Umsatz kein Gewinn und das ist die Grundlage für die Marktkapitalisierung. Und scheinbar scheint der Bedarf hier nicht allzu groß zu sein, den man dringend decken muss, sonst gäbe es schon Plan B

Lasse mich aber gerne überraschen: erst Kurs runter dann neuer can Deal...alles möglich

[Kapitalrendite]

Antwort auf Beitrag Nr.: 63.933.354 von Realdeal99 am 07.06.20 17:21:42

Ich bin bis oben voll....von daher brauche ich nicht versuchen günstig rein zu kommen.....bis zu meinem EK würde es eh nicht fallen denke aber, dass hier einige schmeißen werden morgen.

[Hamburgerjung89]

Antwort auf Beitrag Nr.: 63.934.086 von rene321 am 07.06.20 19:07:42

Glaube ich nicht.

[rene321]

Sehen wir morgen die 0,10 Cent?

[Realdeal99]

Antwort auf Beitrag Nr.: 63.933.378 von Sly72 am 07.06.20 17:25:17

Unter 0,20

Die Phantasien gehen durch